This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

12 May 2011

Teva Reports 7% Increase in Q1 Profit

Teva reports a 7 percent increase in its Q1 net profit to $761 million.

Israel-based Teva Pharmaceutical Industries, the world's largest generic drugmaker, announced yesterday its Q1 financial results and reported a 7% increase in first-quarter profit, driven by sales growth in international markets.


Net income rose to $761m from the $713m reported in the corresponding year-ago period, while adjusted net income, excluding certain one-time items, grew 13% to $936m.


The results come in spite of weakening performance in North America which saw regional sales fall 11% to $2.06bn. Teva has stood behind its fiscal 2011 earnings and sales forecast.


Last week, the firm agreed a $6.8bn cash deal to buy the US-based biotechnology firm Cephalon, beating rivals includi

Related News